China Biologic Products Begins Annual Maintenance of its Production Facilities
TAIAN CITY, Shandong, China, Aug. 1 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company began ...
China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors
TAI'AN, Shandong, China, July 31 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China ("PRC"), today announced that, effective July 24, 2008, it has ap...
China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
TAIAN CITY, Shandong, China /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on July 8, 2008, the Company was awa...
China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
TAIAN CITY, Shandong, China, July 9 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company has co...
China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province
TAIAN CITY, Shandong, China, June 30 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company recei...
China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
TAIAN CITY, China, May 29 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“CBP,” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“China” or the “PRC”), today announced that the Company has b...
China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
TAIAN CITY, Shandong, China, May 22 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“CBP,” or “the Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Company receiv...
China Biologic Products Reports First Quarter 2008 Results
-- Net income increased 19.4% year-over-year to $2.3 million or 11 cents per share basic TAI'AN, Shandong, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP" or the "Company"), one of the leading plasma-based pharmaceutical companies...
China Biologic Products Announces First Quarter 2008 Results Conference Call
TAI’AN CITY, Shandong, China, May 15 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“CBP”, “the Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that it will conduct a co...
China Biologic Products Announces First Quarter 2008 Results Conference Call
TAI'AN CITY, Shandong, China, May 15 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP", "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will conduct a conference call ...
China Biologic Products Announces the Change of CEO and CFO
TAIAN CITY, Shandong, China, May 13 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“CBP,” or “the Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced the appointment of a ne...
China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
TAI’AN, Shandong, China, April 30 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China ("PRC"), today announced that the Company received app...
China Biologic Products Reports Record Fiscal Year 2007 Results
Net Income Before Minority Interest Increased 98.6% Year-Over-Year to $10.2 Million TAIAN CITY, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic,” or “the Company”), one of the leading plasma-based pharmaceutical comp...
China Biologic Products Commences Trading on OTC Bulletin Board
TAI’AN CITY, China, March 4 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“CBP,” or “the Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that on February 29, 2008, it’s c...
China Biologic Products Gains Financial Support from Shandong Provincial Government on the Improvement of Production Facilities
TAI'AN CITY, Shandong, China, Jan. 15 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (Pink sheets: CBPO) ("China Biologic" or the "Company"), one of the leading manufacturers of plasma-based pharmaceutical products in the People's Republic of China ("China" or the "PRC"), today announced t...
China Biologic Products Reports Record Third Quarter 2007 Results
Net Income increased 225.7% year-over-year to $2.3 million or 11 cents per share TAI'AN CITY, Shandong, China, Nov. 15 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (Pink Sheets: CBPO) ("CBP", "the Company"), one of the leading plasma-based pharmaceutical companies in the Peo...
